Payment overview · 2025
General Payments
$16.14
1 reported records · 1 companies
Healthcare provider profile · identity verified
Robert W. Schubert, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · JOLIET, IL · NPI 1245236363
Verified facts
What the public records show
CMS Open Payments records show Robert W. Schubert, M.D. received $16.14 in general payments during 2025 across 1 reported records.
ABBVIE INC. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Synthroid.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ARMOUR THYROID as an associated drug or biological on 50 records involving 11 distinct recipient NPIs. Public Medicare Part D data also shows 17 claims for Armour Thyroid by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYNTHROID as an associated drug or biological on 10655 records involving 4881 distinct recipient NPIs. Public Medicare Part D data also shows 144 claims for Synthroid by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| ABBVIE INC. | Unresolved — no canonical attribution shown | $16.14 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $16.14 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| SYNTHROID Normalized: synthroid |
Drug | ABBVIE INC. | $16.14 | 1 | 2025 |
Source payment records
|
|||||
| UBRELVY Normalized: ubrelvy |
Drug | ABBVIE INC. | $16.14 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| SYNTHROID synthroid |
2025 | Synthroid | 2024 | 144 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | ARMOUR THYROID open payments reported associated product |
CMS Open Payments — General Payments 50 supporting records · 11 recipient NPIs · example record 1201517088 |
Armour Thyroid · 2024 Exact normalized brand match · 1 Part D row |
17 | suppressed by CMS |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | SYNTHROID open payments reported associated product |
CMS Open Payments — General Payments 10655 supporting records · 4881 recipient NPIs · example record 1201352636 |
Synthroid · 2024 Exact normalized brand match · 1 Part D row |
144 | 36 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 1112 | 306 |
| Atorvastatin Calcium | Atorvastatin Calcium | 896 | 267 |
| Losartan Potassium | Losartan Potassium | 543 | 151 |
| Lisinopril | Lisinopril | 521 | 153 |
| Amlodipine Besylate | Amlodipine Besylate | 516 | 149 |
| Pantoprazole Sodium | Pantoprazole Sodium | 489 | 141 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 431 | 130 |
| Metformin Hcl | Metformin Hcl | 405 | 118 |
| Omeprazole | Omeprazole | 355 | 107 |
| Metoprolol Succinate | Metoprolol Succinate | 306 | 96 |
| Hydrochlorothiazide | Hydrochlorothiazide | 294 | 87 |
| Simvastatin | Simvastatin | 279 | 76 |
| Allopurinol | Allopurinol | 263 | 78 |
| Furosemide | Furosemide | 259 | 84 |
| Alprazolam | Alprazolam | 236 | 58 |
| Gabapentin | Gabapentin | 213 | 64 |
| Pravastatin Sodium | Pravastatin Sodium | 181 | 58 |
| Metoprolol Tartrate | Metoprolol Tartrate | 180 | 50 |
| Alendronate Sodium | Alendronate Sodium | 169 | 46 |
| Sertraline Hcl | Sertraline Hcl | 164 | 51 |
| Escitalopram Oxalate | Escitalopram Oxalate | 162 | 50 |
| Tamsulosin Hcl | Tamsulosin Hcl | 161 | 53 |
| Trazodone Hcl | Trazodone Hcl | 158 | 49 |
| Potassium Chloride | Potassium Chloride | 154 | 48 |
| Montelukast Sodium | Montelukast Sodium | 152 | 42 |
| Synthroid | Levothyroxine Sodium | 144 | 36 |
| Meloxicam | Meloxicam | 133 | 42 |
| Carvedilol | Carvedilol | 130 | 42 |
| Ezetimibe | Ezetimibe | 126 | 35 |
| Glipizide | Glipizide | 119 | 32 |
| Famotidine | Famotidine | 116 | 36 |
| Duloxetine Hcl | Duloxetine Hcl | 110 | 24 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 100 | 54 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 97 | 30 |
| Metformin Hcl Er | Metformin Hcl | 93 | 31 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 91 | 24 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 88 | 24 |
| Clopidogrel | Clopidogrel Bisulfate | 83 | 24 |
| Fluticasone Propionate | Fluticasone Propionate | 83 | 38 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 79 | 23 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 78 | 24 |
| Farxiga | Dapagliflozin Propanediol | 77 | 17 |
| Lorazepam | Lorazepam | 75 | 15 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 75 | 24 |
| Pioglitazone Hcl | Pioglitazone Hcl | 69 | 20 |
| Zolpidem Tartrate | Zolpidem Tartrate | 69 | 16 |
| Atenolol | Atenolol | 66 | 17 |
| Celecoxib | Celecoxib | 64 | 20 |
| Fenofibrate | Fenofibrate | 64 | 19 |
| Paroxetine Hcl | Paroxetine Hcl | 60 | 17 |
| Donepezil Hcl | Donepezil Hcl | 59 | 20 |
| Glimepiride | Glimepiride | 57 | 19 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 57 | 37 |
| Mirtazapine | Mirtazapine | 56 | 15 |
| Ozempic | Semaglutide | 56 | 13 |
| Clonazepam | Clonazepam | 55 | 19 |
| Tramadol Hcl | Tramadol Hcl | 54 | 26 |
| Verapamil Er | Verapamil Hcl | 53 | 14 |
| Memantine Hcl | Memantine Hcl | 52 | 14 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 51 | 18 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 51 | 44 |
| Lansoprazole | Lansoprazole | 49 | 13 |
| Fenofibrate | Fenofibrate Nanocrystallized | 48 | 14 |
| Cefadroxil | Cefadroxil | 47 | 40 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 47 | 29 |
| Dicyclomine Hcl | Dicyclomine Hcl | 46 | 12 |
| Prednisone | Prednisone | 46 | 37 |
| Nystatin | Nystatin | 45 | 21 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 45 | 14 |
| Citalopram Hbr | Citalopram Hydrobromide | 44 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 43 | 37 |
| Buspirone Hcl | Buspirone Hcl | 43 | 13 |
| Ibandronate Sodium | Ibandronate Sodium | 43 | suppressed |
| Xarelto | Rivaroxaban | 43 | 12 |
| Bupropion Xl | Bupropion Hcl | 42 | 14 |
| Irbesartan | Irbesartan | 42 | 12 |
| Rybelsus | Semaglutide | 41 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 40 | 12 |
| Fluoxetine Hcl | Fluoxetine Hcl | 40 | 15 |
| Jardiance | Empagliflozin | 39 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 38 | 13 |
| Januvia | Sitagliptin Phosphate | 37 | suppressed |
| Spironolactone | Spironolactone | 37 | 13 |
| Finasteride | Finasteride | 36 | 11 |
| Hydralazine Hcl | Hydralazine Hcl | 36 | 11 |
| Glipizide Er | Glipizide | 35 | 13 |
| Pregabalin | Pregabalin | 35 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 34 | 12 |
| Amoxicillin | Amoxicillin | 34 | 30 |
| Eliquis | Apixaban | 34 | 11 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 33 | 11 |
| Temazepam | Temazepam | 33 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 32 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 31 | suppressed |
| Azithromycin | Azithromycin | 30 | 26 |
| Ventolin Hfa | Albuterol Sulfate | 30 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 30 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 29 | suppressed |
| Valsartan | Valsartan | 29 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 28 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 27 | 24 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 27 | suppressed |
| Lovastatin | Lovastatin | 27 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 26 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 26 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 26 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 26 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 26 | 11 |
| Clonidine Hcl | Clonidine Hcl | 25 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 25 | 19 |
| Ondansetron Odt | Ondansetron | 25 | 15 |
| Oxybutynin Chloride | Oxybutynin Chloride | 25 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 24 | suppressed |
| Colchicine | Colchicine | 22 | 12 |
| Desloratadine | Desloratadine | 22 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 22 | suppressed |
| Acyclovir | Acyclovir | 21 | suppressed |
| Glipizide-Metformin | Glipizide/Metformin Hcl | 21 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 21 | suppressed |
| Methylprednisolone | Methylprednisolone | 21 | 16 |
| Ramipril | Ramipril | 21 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 21 | suppressed |
| Cephalexin | Cephalexin | 20 | 16 |
| Clobetasol Propionate | Clobetasol Propionate | 20 | 12 |
| Ipratropium Bromide | Ipratropium Bromide | 20 | suppressed |
| Telmisartan | Telmisartan | 20 | suppressed |
| Diclofenac Potassium | Diclofenac Potassium | 19 | suppressed |
| Nifedipine Er | Nifedipine | 19 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 19 | 18 |
| Fluconazole | Fluconazole | 18 | 13 |
| Humalog Kwikpen U-100 | Insulin Lispro | 18 | suppressed |
| Armour Thyroid | Thyroid,pork | 17 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 17 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 17 | suppressed |
| Rizatriptan | Rizatriptan Benzoate | 17 | suppressed |
| Sucralfate | Sucralfate | 17 | suppressed |
| Colestipol Hcl | Colestipol Hcl | 16 | suppressed |
| Irbesartan-Hydrochlorothiazide | Irbesartan/Hydrochlorothiazide | 16 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 16 | 12 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 16 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 16 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 15 | 12 |
| Cholestyramine | Cholestyramine (With Sugar) | 15 | suppressed |
| Diazepam | Diazepam | 15 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 15 | suppressed |
| Minocycline Hcl | Minocycline Hcl | 15 | 14 |
| Ondansetron Hcl | Ondansetron Hcl | 15 | suppressed |
| Clonidine | Clonidine | 14 | suppressed |
| Gemfibrozil | Gemfibrozil | 14 | suppressed |
| Klor-Con M20 | Potassium Chloride | 14 | suppressed |
| Lactulose | Lactulose | 14 | suppressed |
| Lidocaine | Lidocaine | 14 | suppressed |
| Naproxen | Naproxen | 14 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 14 | suppressed |
| Carvedilol Er | Carvedilol Phosphate | 13 | suppressed |
| Estradiol | Estradiol | 13 | suppressed |
| Modafinil | Modafinil | 13 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 13 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 13 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 13 | suppressed |
| Aripiprazole | Aripiprazole | 12 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 12 | 12 |
| Hydrocortisone | Hydrocortisone | 12 | suppressed |
| Mounjaro | Tirzepatide | 12 | suppressed |
| Primidone | Primidone | 12 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 12 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 12 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 12 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 12 | suppressed |
| Chlorthalidone | Chlorthalidone | 11 | suppressed |
| Genvoya | Elviteg/Cob/Emtri/Tenof Alafen | 11 | suppressed |
| Novolog Flexpen | Insulin Aspart | 11 | suppressed |
| Risedronate Sodium | Risedronate Sodium | 11 | suppressed |
| Sildenafil Citrate | Sildenafil Citrate | 11 | suppressed |
| Trandolapril | Trandolapril | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $16.14 · 1 records | ABBVIE INC. | SYNTHROID, UBRELVY | 2 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Synthroid play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with ABBVIE INC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error